ophthalmology innovation showcase - clarvista medical
TRANSCRIPT
PowerPoint Presentation
HARMONI Modular IOL SystemPaul McLean President and CEO
5 May 2016
1
2HARMONI Modular IOL Design
2
3HARMONI Development MilestonesTechnologydevelopmentFIH Trial1 Year DataCE Mark3 new trials#1 InnovationStableReplaceableVersatileEasyMulticenterRandomizedControlledConfirmed:StableReplaceableVersatileEasyTrial execution100s of patientsIDE building blocksResults Q4 2016Consistent results
20122013201420152016
3
p=.003
Outstanding ResultsVisual Acuity Average Days ImplantedPre-opAvg. Error (diopters)Post-op Avg. Error (6 month)94-0.90-0.02
ACD StabilityOptic ReplacementBCVA logMARControl HARMONIPCO Development (Pre-clinical)The HARMONI modular IOL is an investigational device and is not approved for use in the United StatesPCO Score
4
ClarVista Highlights 5IOL performance you can count on, versatility and control you crave
Solid foundation, versatile controlOptimized patient outcomesEnhanced stability
Technology for a lifetimeSafe & easy IOL replacement and upgradesIntelligent design choices to decrease PCOOne platform, all patients
Platform technology - outstanding potential to go well beyond refractive correctionThe HARMONI modular IOL is an investigational device and is not approved for use in the United States
5
HARMONI Modular IOL SystemFor more information about the HARMONI Modular IOL please contact:
Paul McLean [email protected]: @ClarVista_Med
6